ON-DEMAND WEBINAR
The AI Inflection Point: 2026 State of Clinical Trial Technology Industry Perspectives
Florence’s annual report is back, and we’re ready to share the results with you on February 17 at 11 a.m. ET. Join us as we share findings from a global survey of 400+ sites, sponsors, and CROs—and unpack what the data reveals about where trial execution is breaking down, what distinguishes leading organizations, and what priorities will matter most in 2026.
Hosted by Florence Chief Clinical Trial Officer Catherine Gregor and Florence CEO Ryan Jones, this session translates the data into clear, practical guidance for clinical operations leaders.
In this webinar, you will learn:
More sites must cross the digital divide by owning systems or using sponsor-provided technology that reduces paper and email and produces operational data as work happens. The leading best-of-breed clinical trial technologies create access and insights where work gets done.
Participant payments, feasibility, recruitment, lab management, contracts, image management, investigational product management and participant consent all have greater than 20% site ownership this year.
AI experimentation is critical and adopters are testing AI on highly manual tasks where a) human effort is greatest and b) data already exists. These early experiments are about learning where digitization, data quality, governance and connectivity must improve to support broader usage.